Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/36097
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBECKERS, Lien-
dc.contributor.authorBAETEN, Paulien-
dc.contributor.authorSWINNEN, Dries-
dc.contributor.authorHAMAD, Ibrahim-
dc.contributor.authorTavernier, S.-
dc.contributor.authorVAN WIJMEERSCH, Bart-
dc.contributor.authorPOPESCU, Veronica-
dc.contributor.authorKLEINEWIETFELD, Markus-
dc.contributor.authorBROUX, Bieke-
dc.contributor.authorFRAUSSEN, Judith-
dc.contributor.authorSOMERS, Veerle-
dc.date.accessioned2021-12-08T15:45:58Z-
dc.date.available2021-12-08T15:45:58Z-
dc.date.issued2021-
dc.date.submitted2021-12-08T12:25:29Z-
dc.identifier.citationMULTIPLE SCLEROSIS JOURNAL, 27 (2_SUPPL) , p. 777 -778-
dc.identifier.urihttp://hdl.handle.net/1942/36097-
dc.description.sponsorshipBelgian Charcot Foundation-
dc.language.isoen-
dc.publisherSAGE PUBLICATIONS LTD-
dc.titleCharacterisation of the innate and adaptive immune system after ocrelizumab treatment in multiple sclerosis-
dc.typeJournal Contribution-
dc.identifier.epage778-
dc.identifier.issue2_SUPPL-
dc.identifier.spage777-
dc.identifier.volume27-
local.format.pages2-
local.bibliographicCitation.jcatM-
local.publisher.place1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
dc.identifier.isiWOS:000706771302335-
local.provider.typewosris-
local.uhasselt.uhpubyes-
local.description.affiliation[Beckers, L.; Baeten, P.; Swinnen, D.; Hamad, I.; Van Wijmeersch, B.; Popescu, V.; Kleinewietfeld, M.; Broux, B.; Fraussen, J.; Somers, V.] Univ MS Ctr UMSC, Hasselt Pelt, Belgium.-
local.description.affiliation[Beckers, L.; Baeten, P.; Swinnen, D.; Hamad, I.; Van Wijmeersch, B.; Popescu, V.; Kleinewietfeld, M.; Broux, B.; Fraussen, J.; Somers, V.] Hasselt Univ, Biomed Res Inst, Dept Immunol & infect, Hasselt, Belgium.-
local.description.affiliation[Swinnen, D.; Hamad, I.] VIB Lab Translat Immunomodulat, Ctr Inflammat Res IRC, Diepenbeek, Belgium.-
local.description.affiliation[Tavernier, S.] Univ Ghent, Dept Internal Med & Pediat, Ghent, Belgium.-
local.description.affiliation[Tavernier, S.] VIB Univ Ghent, Ctr Inflammat Res IRC, Unit Mol Signal Transduct inflammat, Ghent, Belgium.-
local.description.affiliation[Van Wijmeersch, B.; Popescu, V.] Noorderhart, Rehabil & MS Ctr, Pelt, Belgium.-
local.uhasselt.internationalno-
item.contributorBECKERS, Lien-
item.contributorBAETEN, Paulien-
item.contributorSWINNEN, Dries-
item.contributorHAMAD, Ibrahim-
item.contributorTavernier, S.-
item.contributorVAN WIJMEERSCH, Bart-
item.contributorPOPESCU, Veronica-
item.contributorKLEINEWIETFELD, Markus-
item.contributorBROUX, Bieke-
item.contributorFRAUSSEN, Judith-
item.contributorSOMERS, Veerle-
item.fullcitationBECKERS, Lien; BAETEN, Paulien; SWINNEN, Dries; HAMAD, Ibrahim; Tavernier, S.; VAN WIJMEERSCH, Bart; POPESCU, Veronica; KLEINEWIETFELD, Markus; BROUX, Bieke; FRAUSSEN, Judith & SOMERS, Veerle (2021) Characterisation of the innate and adaptive immune system after ocrelizumab treatment in multiple sclerosis. In: MULTIPLE SCLEROSIS JOURNAL, 27 (2_SUPPL) , p. 777 -778.-
item.fulltextNo Fulltext-
item.accessRightsClosed Access-
crisitem.journal.eissn2055-2173-
Appears in Collections:Research publications
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.